Compared to Estimates, ProAssurance (PRA) Q4 Earnings: A Look at Key Metrics

ProAssurance (PRA) reported $287.52 million in revenue for the quarter ended December 2024, representing a year-over-year increase of 0.9%. EPS of $0.36 for the same period compares to -$0.05 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $271.98 million, representing a surprise of +5.71%. The company delivered an EPS surprise of +140.00%, with the consensus EPS estimate being $0.15.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how ProAssurance performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Net Loss Ratio: 75.7% versus the five-analyst average estimate of 78.6%. Underwriting Expense Ratio: 33.6% versus 33.1% estimated by five analysts on average. Combined Ratio: 109.3% compared to the 111.7% average estimate based on five analysts. Net Loss Ratio - Workers Compensation: 75.7% compared to the 80.9% average estimate based on three analysts. Net premiums earned: $241.07 million versus the five-analyst average estimate of $231.24 million. The reported number represents a year-over-year change of -2.5%. Net investment income: $36.81 million compared to the $37.73 million average estimate based on five analysts. The reported number represents a change of +9.2% year over year. Equity in earnings (loss) of unconsolidated subsidiaries: $5.82 million versus $3.04 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +334% change. Other income(loss): $9.64 million versus the five-analyst average estimate of $3.01 million. The reported number represents a year-over-year change of +146.3%. Net Premiums Earned- Specialty Property & Casualty: $185.81 million compared to the $183.36 million average estimate based on three analysts. The reported number represents a change of -4% year over year. Net Premiums Earned- Segregated Portfolio Cell Reinsurance: $12.35 million versus $12.93 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -19.8% change. Net Premiums Earned- Workers Compensation: $42.92 million compared to the $39.89 million average estimate based on three analysts. The reported number represents a change of +12% year over year. Net investment income- Segregated Portfolio Cell Reinsurance: $0.92 million compared to the $0.85 million average estimate based on two analysts. The reported number represents a change of +38.7% year over year. View all Key Company Metrics for ProAssurance here>>>Shares of ProAssurance have returned -5.3% over the past month versus the Zacks S&P 500 composite's -0.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Just Released: Zacks Top 10 Stocks for 2025Hurry – you can still get in early on our 10 top tickers for 2025. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2025. You can still be among the first to see these just-released stocks with enormous potential. See New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ProAssurance Corporation (PRA): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks